DZ3249A1 - Procédé d'administration d'un inhibiteur phosphodiesterase 4 - Google Patents

Procédé d'administration d'un inhibiteur phosphodiesterase 4

Info

Publication number: DZ3249A1
Authority: DZ; Algeria
Prior art keywords: phosphodiesterase; administering; inhibitor
Prior art date: 1999-10-29

Application number

DZ003249A

Other languages

English (en)

Inventor

Robert D Murdoch

Theodore J Torphy

Barry D Zussman

Original Assignee

Smithkline Beecham Corp

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-29

Filing date

2000-10-26

Publication date

2001-05-10

2000-10-26 Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp

2001-05-10 Application granted granted Critical

2001-05-10 Publication of DZ3249A1 publication Critical patent/DZ3249A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)

DZ003249A 1999-10-29 2000-10-26 Procédé d'administration d'un inhibiteur phosphodiesterase 4 DZ3249A1 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US16247799P	1999-10-29	1999-10-29
US16264199P	1999-11-01	1999-11-01
US17981700P	2000-02-02	2000-02-02
PCT/US2000/029453 WO2001032165A1 (fr)	1999-10-29	2000-10-26	Procede d'administration d'un inhibiteur phosphodiesterase 4

Publications (1)

Publication Number	Publication Date
DZ3249A1 true DZ3249A1 (fr)	2001-05-10

Family

ID=27388757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003249A DZ3249A1 (fr)	1999-10-29	2000-10-26	Procédé d'administration d'un inhibiteur phosphodiesterase 4

Country Status (29)

Country	Link
US (1)	US20030212112A1 (fr)
EP (1)	EP1225884A4 (fr)
JP (1)	JP2003513038A (fr)
KR (1)	KR20020050249A (fr)
CN (1)	CN1387433A (fr)
AP (1)	AP2002002446A0 (fr)
AR (1)	AR026254A1 (fr)
AU (1)	AU772909B2 (fr)
BG (1)	BG106623A (fr)
BR (1)	BR0015039A (fr)
CA (1)	CA2389293A1 (fr)
CO (1)	CO5271676A1 (fr)
CZ (1)	CZ20021443A3 (fr)
DZ (1)	DZ3249A1 (fr)
EA (1)	EA200200502A1 (fr)
HK (1)	HK1049105A1 (fr)
HU (1)	HUP0203682A3 (fr)
IL (1)	IL148813A0 (fr)
MA (1)	MA25562A1 (fr)
MX (1)	MXPA02004220A (fr)
NO (1)	NO20021937L (fr)
NZ (1)	NZ518002A (fr)
OA (1)	OA12078A (fr)
PE (1)	PE20011004A1 (fr)
PL (1)	PL355262A1 (fr)
SK (1)	SK7292002A3 (fr)
TR (1)	TR200201150T2 (fr)
UY (1)	UY26422A1 (fr)
WO (1)	WO2001032165A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR029984A1 (es) *	2000-07-27	2003-07-23	Smithkline Beecham Corp	Metodo para reducir las exacerbaciones asociadas copd ambito
MY140561A (en)	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
DE10207160A1 (de) *	2002-02-20	2003-12-18	Altana Pharma Ag	Darreichungsform enthaltend PDE 4-Hemmer als Wirkstoff
ES2319517T3 (es) *	2002-05-28	2009-05-08	Nycomed Gmbh	Preparacion farmaceutica aplicable topicamente.
US6822114B1 (en)	2002-10-08	2004-11-23	Albemarle Corporation	Process for production of fluoroalkoxy-substituted benzamides and their intermediates
PL1606261T3 (pl)	2003-03-10	2010-04-30	Astrazeneca Ab	Nowy sposób przygotowania roflumilastu
CA2520779A1 (fr) *	2003-03-31	2004-11-11	Kyowa Hakko Kogyo Co., Ltd.	Agent administre par voie orale
US20050026883A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
EP1861074B1 (fr)	2005-03-16	2013-04-24	Takeda GmbH	Forme de dosage cachant le goût comprenant du roflumilaste
MX2012006265A (es) *	2009-12-03	2012-07-25	Opko Health Inc	Formulaciones disacaridas hipersulfatadas.
WO2013101810A1 (fr) *	2011-12-27	2013-07-04	Celgene Corporation	Formulations de (+)-2-[1-(3-éthoxy-4-méthoxy-phényl)-2-méthanesulfonyl-éthyl]-4-acétylaminoisoindoline-1,3-dione
CN103536582A (zh) *	2013-10-12	2014-01-29	云南龙海天然植物药业有限公司	罗氟司特干粉吸入剂
US20210031012A1 (en)	2018-01-26	2021-02-04	Progenity, Inc.	Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor
CN113348011B (zh)	2018-11-19	2023-04-18	比奥拉治疗股份有限公司	用生物治疗剂治疗疾病的方法和装置
WO2021119482A1 (fr)	2019-12-13	2021-06-17	Progenity, Inc.	Dispositif ingérable pour administrer un agent thérapeutique dans le tractus gastro-intestinal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4684516A (en) *	1983-08-01	1987-08-04	Alra Laboratories, Inc.	Sustained release tablets and method of making same
AR028986A1 (es) *	1999-02-23	2003-06-04	Smithkline Beecham Corp	USO DE UN INHIBIDOR DE PDE4 EN LA FABRICACIoN DE UNA PREPARACIoN DE LIBERACIoN CONTROLADA; FORMULACION DE LIBERACION CONTROLADA PARA EL TRATAMIENTO DE COPD, UN PROCEDIMIENTO PARA SU PREPARACIoN Y COMPOSICIoN FARMACÉUTICA
AR035987A1 (es) *	1999-03-01	2004-08-04	Smithkline Beecham Corp	Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio

2000
- 2000-10-26 IL IL14881300A patent/IL148813A0/xx unknown
- 2000-10-26 HU HU0203682A patent/HUP0203682A3/hu unknown
- 2000-10-26 KR KR1020027005448A patent/KR20020050249A/ko not_active Application Discontinuation
- 2000-10-26 EP EP00975385A patent/EP1225884A4/fr not_active Withdrawn
- 2000-10-26 BR BR0015039-8A patent/BR0015039A/pt not_active IP Right Cessation
- 2000-10-26 AP APAP/P/2002/002446A patent/AP2002002446A0/en unknown
- 2000-10-26 TR TR2002/01150T patent/TR200201150T2/xx unknown
- 2000-10-26 CO CO00081570A patent/CO5271676A1/es not_active Application Discontinuation
- 2000-10-26 CA CA002389293A patent/CA2389293A1/fr not_active Abandoned
- 2000-10-26 AU AU13445/01A patent/AU772909B2/en not_active Ceased
- 2000-10-26 JP JP2001534370A patent/JP2003513038A/ja not_active Withdrawn
- 2000-10-26 CN CN00815150A patent/CN1387433A/zh active Pending
- 2000-10-26 OA OA1200200126A patent/OA12078A/en unknown
- 2000-10-26 AR ARP000105644A patent/AR026254A1/es not_active Application Discontinuation
- 2000-10-26 DZ DZ003249A patent/DZ3249A1/fr active
- 2000-10-26 EA EA200200502A patent/EA200200502A1/ru unknown
- 2000-10-26 SK SK729-2002A patent/SK7292002A3/sk unknown
- 2000-10-26 MX MXPA02004220A patent/MXPA02004220A/es unknown
- 2000-10-26 CZ CZ20021443A patent/CZ20021443A3/cs unknown
- 2000-10-26 WO PCT/US2000/029453 patent/WO2001032165A1/fr not_active Application Discontinuation
- 2000-10-26 PL PL00355262A patent/PL355262A1/xx unknown
- 2000-10-26 NZ NZ518002A patent/NZ518002A/en unknown
- 2000-10-27 PE PE2000001157A patent/PE20011004A1/es not_active Application Discontinuation
- 2000-10-30 UY UY26422A patent/UY26422A1/es not_active Application Discontinuation
2002
- 2002-04-17 BG BG106623A patent/BG106623A/bg unknown
- 2002-04-24 NO NO20021937A patent/NO20021937L/no not_active Application Discontinuation
- 2002-04-26 MA MA26618A patent/MA25562A1/fr unknown
- 2002-12-19 HK HK02109231.8A patent/HK1049105A1/zh unknown
2003
- 2003-05-02 US US10/429,666 patent/US20030212112A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PE20011004A1 (es)	2001-09-28
CN1387433A (zh)	2002-12-25
BR0015039A (pt)	2002-06-25
TR200201150T2 (tr)	2002-09-23
JP2003513038A (ja)	2003-04-08
WO2001032165A1 (fr)	2001-05-10
EP1225884A1 (fr)	2002-07-31
AU1344501A (en)	2001-05-14
NZ518002A (en)	2004-01-30
CA2389293A1 (fr)	2001-05-10
BG106623A (bg)	2003-02-28
OA12078A (en)	2003-05-28
AR026254A1 (es)	2003-02-05
IL148813A0 (en)	2002-09-12
CO5271676A1 (es)	2003-04-30
HUP0203682A3 (en)	2003-10-28
NO20021937L (no)	2002-05-30
AP2002002446A0 (en)	2002-03-31
CZ20021443A3 (cs)	2003-01-15
US20030212112A1 (en)	2003-11-13
MXPA02004220A (es)	2002-10-17
NO20021937D0 (no)	2002-04-24
EA200200502A1 (ru)	2002-10-31
HUP0203682A2 (hu)	2003-04-28
KR20020050249A (ko)	2002-06-26
AU772909B2 (en)	2004-05-13
UY26422A1 (es)	2001-07-31
SK7292002A3 (en)	2002-12-03
PL355262A1 (en)	2004-04-05
HK1049105A1 (zh)	2003-05-02
EP1225884A4 (fr)	2005-06-15
MA25562A1 (fr)	2002-10-01

Publication	Publication Date	Title
DZ3249A1 (fr)	2001-05-10	Procédé d'administration d'un inhibiteur phosphodiesterase 4
EE200000361A (et)	2001-10-15	Seade ravimit sisaldava vedeliku manustamiseks
IL145581A0 (en)	2002-11-10	A modified release pharmaceutical composition comprising amoxycillin
LU92315I2 (fr)	2014-01-27	Combinaison comprenant aliskiren, ou un de ses sels pharmaceutiquement acceptable, et amlodipine, ouun de ses sels pharmaceutiquement acceptable
NO943761L (no)	1995-04-10	Oralt administrerbare opioide formuleringer med forlenget effektvarighet
IL146428A0 (en)	2002-07-25	A method for delivering medication into an arterial wall for prevention of restenosis
HUP0301164A3 (en)	2005-11-28	Method of administering bisphosphonates
ITGE20000114A0 (it)	2000-09-13	Dispositivo per l'agugliatura di un'ovatta.
HUP0000536A2 (en)	2002-08-28	Method for levelling a track
IL139450A0 (en)	2001-11-25	Methods of administering apo b-secretion/mtp inhibitors
AU6128301A (en)	2001-12-03	Method of administering a bisphosphonate
NO20012976D0 (no)	2001-06-15	Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
ITGE20000080A0 (it)	2000-06-02	Dispositivo per l'agugliatura di un'ovatta.
NO20000811D0 (no)	2000-02-18	Fremgangsmåte for valg av medicament
DK0866699T3 (da)	2002-08-12	Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
NO20012226D0 (no)	2001-05-04	Terapeutiske midler for medikamentavhengighet
EE200000401A (et)	2001-10-15	Farmatseutilise preparaadi valmistamismeetod
SI1296689T1 (sl)	2006-08-31	Nacin dajanja pacientu bisfosfonatov
FR2801584B1 (fr)	2003-05-30	Procede de preparation d'un compose polyaromatique
GB0008928D0 (en)	2000-05-31	A method of administering an antitumour compound
ITGE20000116A0 (it)	2000-09-27	Dispositivo per l'agugliatura di un'ovatta.
GB0207532D0 (en)	2002-05-08	A novel method for the administration of secretin
CA89010S (en)	2000-03-31	Injector for administration of pharmaceutical agents
IT1320774B1 (it)	2003-12-10	Composizione farmaceutica per uso parenterale contenente un compostodella classe delle cefalosporine
IT1307634B1 (it)	2001-11-14	Dispositivo di fissaggio per tubi atto ad impedirne l'arrampicabilita'